IRIS Accounts Production v26.3.0.614 08195405 Board of Directors Board of Directors 1.2.25 31.1.26 31.1.26 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh081954052025-01-31081954052026-01-31081954052025-02-012026-01-31081954052024-01-31081954052024-02-012025-01-31081954052025-01-3108195405ns15:EnglandWales2025-02-012026-01-3108195405ns14:PoundSterling2025-02-012026-01-3108195405ns10:Director12025-02-012026-01-3108195405ns10:Director22025-02-012026-01-3108195405ns10:PrivateLimitedCompanyLtd2025-02-012026-01-3108195405ns10:SmallEntities2025-02-012026-01-3108195405ns10:AuditExempt-NoAccountantsReport2025-02-012026-01-3108195405ns10:SmallCompaniesRegimeForDirectorsReport2025-02-012026-01-3108195405ns10:SmallCompaniesRegimeForAccounts2025-02-012026-01-3108195405ns10:FullAccounts2025-02-012026-01-310819540512025-02-012026-01-3108195405ns10:RegisteredOffice2025-02-012026-01-3108195405ns5:CurrentFinancialInstruments2026-01-3108195405ns5:CurrentFinancialInstruments2025-01-3108195405ns5:ShareCapital2026-01-3108195405ns5:ShareCapital2025-01-3108195405ns5:RetainedEarningsAccumulatedLosses2026-01-3108195405ns5:RetainedEarningsAccumulatedLosses2025-01-3108195405ns5:NetGoodwill2025-02-012026-01-3108195405ns5:FurnitureFittings2025-02-012026-01-3108195405ns5:ComputerEquipment2025-02-012026-01-3108195405ns5:NetGoodwill2025-01-3108195405ns5:NetGoodwill2026-01-3108195405ns5:NetGoodwill2025-01-3108195405ns5:FurnitureFittings2025-01-3108195405ns5:ComputerEquipment2025-01-3108195405ns5:FurnitureFittings2026-01-3108195405ns5:ComputerEquipment2026-01-3108195405ns5:FurnitureFittings2025-01-3108195405ns5:ComputerEquipment2025-01-3108195405ns5:WithinOneYearns5:CurrentFinancialInstruments2026-01-3108195405ns5:WithinOneYearns5:CurrentFinancialInstruments2025-01-3108195405ns5:WithinOneYear2026-01-3108195405ns5:WithinOneYear2025-01-3108195405ns5:BetweenOneFiveYears2026-01-3108195405ns5:BetweenOneFiveYears2025-01-3108195405ns5:AllPeriods2026-01-3108195405ns5:AllPeriods2025-01-3108195405ns5:Secured2026-01-3108195405ns5:Secured2025-01-3108195405ns10:Director112025-01-3108195405ns10:Director112024-01-3108195405ns10:Director112025-02-012026-01-3108195405ns10:Director112024-02-012025-01-3108195405ns10:Director112026-01-3108195405ns10:Director112025-01-31081954052ns10:Director22025-01-31081954052ns10:Director22024-01-31081954052ns10:Director22025-02-012026-01-31081954052ns10:Director22024-02-012025-01-31081954052ns10:Director22026-01-31081954052ns10:Director22025-01-31
REGISTERED NUMBER: 08195405 (England and Wales)















Financial Statements for the Year Ended 31 January 2026

for

Pharmcare Limited

Pharmcare Limited (Registered number: 08195405)






Contents of the Financial Statements
for the Year Ended 31 January 2026




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Pharmcare Limited

Company Information
for the Year Ended 31 January 2026







DIRECTORS: D S Brash
Mrs K K Mudhar





REGISTERED OFFICE: Mitchell's Chemist
88 New Road Side
Horsforth
Leeds
West Yorkshire
LS18 4QB





REGISTERED NUMBER: 08195405 (England and Wales)





ACCOUNTANTS: Richard Smedley Limited
Chartered Accountants & Registered Auditors
Richmond House
Lawnswood Business Park
Redvers Close
Leeds
West Yorkshire
LS16 6QY

Pharmcare Limited (Registered number: 08195405)

Balance Sheet
31 January 2026

31.1.26 31.1.25
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 90,085 135,126
Tangible assets 5 7,287 4,658
97,372 139,784

CURRENT ASSETS
Stocks 130,461 131,984
Debtors 6 217,785 192,060
Cash at bank and in hand 104,948 108,787
453,194 432,831
CREDITORS
Amounts falling due within one year 7 262,391 315,604
NET CURRENT ASSETS 190,803 117,227
TOTAL ASSETS LESS CURRENT
LIABILITIES

288,175

257,011

PROVISIONS FOR LIABILITIES 1,467 748
NET ASSETS 286,708 256,263

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 286,608 256,163
SHAREHOLDERS' FUNDS 286,708 256,263

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Pharmcare Limited (Registered number: 08195405)

Balance Sheet - continued
31 January 2026


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 20 October 2026 and were signed on its behalf by:




D S Brash - Director



Mrs K K Mudhar - Director


Pharmcare Limited (Registered number: 08195405)

Notes to the Financial Statements
for the Year Ended 31 January 2026

1. STATUTORY INFORMATION

Pharmcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover comprises the value of sales (excluding VAT, similar taxes and trade discounts) of goods and services provided in the normal course of business. Counter sales and prescriptions are recognised when the goods are dispensed.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2013 and the directors have estimated the useful life to be fifteen years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 15% on reducing balance
Computer equipment - Straight line over 3 years

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Financial instruments
Basic financial instruments are recognised at amortised cost. Derivative financial instruments are initially recorded at cost and thereafter at fair value with changes recognised in profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Pharmcare Limited (Registered number: 08195405)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2026

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 16 (2025 - 16 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 February 2025
and 31 January 2026 675,603
AMORTISATION
At 1 February 2025 540,477
Charge for year 45,041
At 31 January 2026 585,518
NET BOOK VALUE
At 31 January 2026 90,085
At 31 January 2025 135,126

Pharmcare Limited (Registered number: 08195405)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2026

5. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 February 2025 14,610 3,346 17,956
Additions 3,600 400 4,000
At 31 January 2026 18,210 3,746 21,956
DEPRECIATION
At 1 February 2025 9,952 3,346 13,298
Charge for year 1,239 132 1,371
At 31 January 2026 11,191 3,478 14,669
NET BOOK VALUE
At 31 January 2026 7,019 268 7,287
At 31 January 2025 4,658 - 4,658

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.26 31.1.25
£    £   
Trade debtors 162,971 126,290
Other debtors 54,814 65,770
217,785 192,060

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.26 31.1.25
£    £   
Bank loans and overdrafts 4,167 14,167
Trade creditors 173,901 209,218
Taxation and social security 62,985 59,872
Other creditors 21,338 32,347
262,391 315,604

8. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
31.1.26 31.1.25
£    £   
Within one year 26,324 23,924
Between one and five years 32,300 49,300
58,624 73,224

Pharmcare Limited (Registered number: 08195405)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2026

9. SECURED DEBTS

The following secured debts are included within creditors:

31.1.26 31.1.25
£    £   
Bank loans 4,167 14,167

The loans are secured via a debenture from Santander UK PLC over all the company's assets and undertakings. Santander UK PLC hold a first legal mortgage over the leasehold property and a subordination/priority deed over all other lenders to the company.

10. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 January 2026 and 31 January 2025:

31.1.26 31.1.25
£    £   
D S Brash
Balance outstanding at start of year - 7,782
Amounts advanced 9,856 56,074
Amounts repaid (9,856 ) (63,856 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year - -

Mrs K K Mudhar
Balance outstanding at start of year 1,681 9,596
Amounts advanced 10,000 56,085
Amounts repaid (11,681 ) (64,000 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year - 1,681

The directors have given a personal guarantee to the bank limited to £200,000.